(Q36736397)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17302562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: current practice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17302562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17302562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Ian D Davis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17302562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Damien M Bolton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17302562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Andrew M Scott

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17302562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17302562%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Urology

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17302562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17302562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17302562%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

89-95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17302562%20AND%20SRC:MED&resulttype=core&format=json

The role of nuclear medicine in clinical investigation

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Diagnosis of Occult Bone Metastases: Positron Emission Tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Is prostate-specific antigen a reliable marker of bone metastasis in patients with newly diagnosed cancer of the prostate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Baseline staging of newly diagnosed prostate cancer: a summary of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Positron emission tomography for prostate, bladder, and renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

The serum level of the amino-terminal propeptide of type I procollagen is a sensitive marker for prostate cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Evaluation and management of men whose radical prostatectomies failed: results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Limited value of bone scintigraphy and computed tomography in assessing biochemical failure after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Percentage of the positive area of bone metastasis is an independent predictor of disease death in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

The management of intractable bone pain: a clinician's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Radionuclide therapy of intractable bone pain: emphasis on strontium-89

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Samarium-153 EDTMP therapy of disseminated skeletal metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Radioisotopic treatment of bone pain from metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X

Nuclear medicine techniques for the diagnosis and therapy of prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01659.X